Search Results - T. A. Binder
- Showing 1 - 3 results of 3
-
1
A randomized study to evaluate the safety and efficacy of two dosages of lenvatinib – 18 and 24 mg – in patients with radioiodrefract differentiated thyroid cancer by M. S. Brose, Yu. Panaseykin, B. Konda, C. de la Fouchardiere, B. G.M. Hughes, A. G. Gianoukakis, Y. J. Park, I. Romanov, M. K. Krzyzanowska, S. Leboulleux, T. A. Binder, C. Dutcus, R. Xie, M. H. Taylor
Published 2022-04-01
Article -
2
Identifying and exploiting combinatorial synthetic lethality by characterizing adaptive kinome rewiring of EGFRvIII-driven glioblastoma by Benjamin Lin, Abigail K. Shelton, Erin Smithberger, Julia Ziebro, Kasey R. Skinner, Ryan E. Bash, Richard Kirkman, Allie Stamper, Madison Butler, Alex Flores, Steven P. Angus, Michael P. East, Timothy F. Cloughesy, David A. Nathanson, Michael E. Berens, Jann N. Sarkaria, Zev A. Binder, Donald M. O’Rourke, Timothy C. Howton, Brittany N. Lasseigne, Christopher D. Willey, Gary L. Johnson, Anita B. Hjelmeland, Frank B. Furnari, C. Ryan Miller
Published 2025-06-01
Article -
3
Discovery of Clonixeril as a Sub-Femtomolar Modulator of the Human STING Receptor by Robert P. Sparks, William Lawless, Anna Kharitonova, Rainer Metcalf, Jamie Nunziata, Grace A. Binder, Sauradip Chaudhuri, Christine S.R. Gambino, Michelle Wilde, Linette S. Harding, Jaret J. Crews, Mansi Gopu, Emilia Dalamangas, Sarah Lawless, Mark Eschenfelder, Robert M. Green, Elizabeth X Nompleggi, Timothy H. Tran, Yan Yang, Donna V. Trask, Paul R. Thompson, Rekha Patel, Niketa A. Patel, Wesley H. Brooks, Guy Bradley, Mildred E. Acevedo-Duncan, Alan C. Mullen, James W. Leahy, Kenyon G. Daniel, Wayne C. Guida
Published 2025-06-01
Article